RxSight (RXST) Receivables - Net (2020 - 2026)
RxSight filings provide 6 years of Receivables - Net readings, the most recent being $23.4 million for Q4 2025.
- On a quarterly basis, Receivables - Net fell 22.19% to $23.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $23.4 million, a 22.19% decrease, with the full-year FY2025 number at $23.4 million, down 22.19% from a year prior.
- Receivables - Net hit $23.4 million in Q4 2025 for RxSight, down from $24.2 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $31.0 million in Q1 2025 to a low of $3.9 million in Q2 2021.
- Median Receivables - Net over the past 5 years was $15.2 million (2023), compared with a mean of $16.7 million.
- Biggest five-year swings in Receivables - Net: surged 125.34% in 2022 and later dropped 22.19% in 2025.
- RxSight's Receivables - Net stood at $4.9 million in 2021, then surged by 125.34% to $11.0 million in 2022, then skyrocketed by 85.11% to $20.3 million in 2023, then skyrocketed by 48.17% to $30.0 million in 2024, then fell by 22.19% to $23.4 million in 2025.
- The last three reported values for Receivables - Net were $23.4 million (Q4 2025), $24.2 million (Q3 2025), and $28.1 million (Q2 2025) per Business Quant data.